Biomaterial Database

Prospects for newer technologies in cervical cancer screening programmes. 1995

D M Hailey, and R Lea

Australian Institute of Health and Welfare, Canberra, Australia.

Because of the limitations of the Pap smear test, much attention has been given to development of technologies to increase the reliability of routine cervical cytology. Newer technologies in this field include automated slide preparation devices, automated slide readers, direct visualization methods and application of flow cytometry and nuclear magnetic resonance. These technologies show promise, but data on their costs, efficacy and effectiveness remain limited. Their introduction in Australia should be linked to local trials, and consideration of their impact on mortality and morbidity and on health care budgets.

UI	MeSH Term	Description	Entries
D008403	Mass Screening	Organized periodic procedures performed on large groups of people for the purpose of detecting disease.	Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D002583	Uterine Cervical Neoplasms	Tumors or cancer of the UTERINE CERVIX.	Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003362	Cost-Benefit Analysis	A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes.	Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001315	Australia	The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.	Canton and Enderbury Islands,Christmas Island,Christmas Island (Australia)
D013677	Medical Laboratory Science	The specialty related to the performance of techniques in clinical pathology such as those in hematology, microbiology, and other general clinical laboratory applications.	Medical Laboratory Technology,Technology, Medical Laboratory,Clinical Laboratory Science,Clinical Laboratory Sciences,Laboratory Science, Clinical,Laboratory Science, Medical,Laboratory Sciences, Clinical,Laboratory Sciences, Medical,Laboratory Technologies, Medical,Laboratory Technology, Medical,Medical Laboratory Sciences,Medical Laboratory Technologies,Science, Clinical Laboratory,Science, Medical Laboratory,Sciences, Clinical Laboratory,Sciences, Medical Laboratory,Technologies, Medical Laboratory
D014626	Vaginal Smears	Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.	Cervical Smears,Cervical Smear,Smear, Cervical,Smear, Vaginal,Smears, Cervical,Smears, Vaginal,Vaginal Smear
D065006	Papanicolaou Test	Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.	Papanicolaou Smear,Pap Smear,Pap Test,Smear, Pap,Smear, Papanicolaou,Test, Pap,Test, Papanicolaou